S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

Eisai Stock Price, News & Analysis (OTCMKTS:ESALY)

$51.32
+0.01 (+0.02 %)
(As of 10/21/2019 04:00 PM ET)
Today's Range
$51.18
Now: $51.32
$51.70
50-Day Range
$48.96
MA: $50.52
$52.38
52-Week Range
$48.52
Now: $51.32
$95.31
Volume5,007 shs
Average Volume8,487 shs
Market Capitalization$14.70 billion
P/E Ratio25.79
Dividend Yield2.38%
Beta0.26
Eisai Co, Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. It develops Fycompa, an antiepileptic drug in the neurology area that is approved as an adjunctive therapy for partial-onset seizures in Japan, the United States, Europe, and Asia. The company is also approved for use as monotherapy for the treatment of partial onset seizures in the United States; and as an adjunctive therapy for primary generalized tonic-clonic seizures in Japan, the United States, Europe, and Asia. Read More…

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ESALY
CUSIPN/A
Phone813-3817-3700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$5.79 billion
Cash Flow$2.84 per share
Book Value$20.48 per share

Profitability

Net Income$570.47 million

Miscellaneous

Employees10,456
Market Cap$14.70 billion
Next Earnings Date11/7/2019 (Estimated)
OptionableNot Optionable

Receive ESALY News and Ratings via Email

Sign-up to receive the latest news and ratings for ESALY and its competitors with MarketBeat's FREE daily newsletter.


Eisai (OTCMKTS:ESALY) Frequently Asked Questions

What is Eisai's stock symbol?

Eisai trades on the OTCMKTS under the ticker symbol "ESALY."

How were Eisai's earnings last quarter?

Eisai Co., Ltd (OTCMKTS:ESALY) announced its earnings results on Wednesday, July, 31st. The company reported $0.69 earnings per share (EPS) for the quarter. The company had revenue of $1.40 billion for the quarter. Eisai had a return on equity of 11.32% and a net margin of 11.33%. View Eisai's Earnings History.

When is Eisai's next earnings date?

Eisai is scheduled to release their next quarterly earnings announcement on Thursday, November 7th 2019. View Earnings Estimates for Eisai.

What guidance has Eisai issued on next quarter's earnings?

Eisai updated its FY 2019 earnings guidance on Wednesday, July, 31st. The company provided EPS guidance of $2.31-2.31 for the period. The company issued revenue guidance of $6.256-6.256 billion.

What is the consensus analysts' recommendation for Eisai?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Eisai in the last year. There are currently 3 sell ratings, 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Eisai.

Has Eisai been receiving favorable news coverage?

Media coverage about ESALY stock has been trending somewhat positive recently, InfoTrie reports. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Eisai earned a news impact score of 0.8 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Eisai.

Who are some of Eisai's key competitors?

What other stocks do shareholders of Eisai own?

Who are Eisai's key executives?

Eisai's management team includes the folowing people:
  • Mr. Haruo Naito, CEO, Representative Corp. Officer & Director (Age 72)
  • Mr. Gary Hendler, Sr. VP & Pres of EMEA Region (Age 53)
  • Dr. Lynn D. Kramer, VP and Chief Clinical Officer & Chief Medical Officer - Neurology Bus. Group (Age 69)
  • Mr. Alexander Scott, VP, Chief Strategy Officer & Head of Strategy Dept. - Neurology Bus. Group
  • Ms. Shaji Procida, VP and Pres & COO of Eisai Inc. (Age 48)

How do I buy shares of Eisai?

Shares of ESALY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Eisai's stock price today?

One share of ESALY stock can currently be purchased for approximately $51.32.

How big of a company is Eisai?

Eisai has a market capitalization of $14.70 billion and generates $5.79 billion in revenue each year. The company earns $570.47 million in net income (profit) each year or $1.99 on an earnings per share basis. Eisai employs 10,456 workers across the globe.View Additional Information About Eisai.

What is Eisai's official website?

The official website for Eisai is http://www.eisai.co.jp/.

How can I contact Eisai?

Eisai's mailing address is 4-6-10 Koishikawa Bunkyo-ku, Tokyo M0, 112-8088. The company can be reached via phone at 813-3817-3700.


MarketBeat Community Rating for Eisai (OTCMKTS ESALY)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  191 (Thanks for Voting!)
Underperform Votes:  192 (Thanks for Voting!)
Total Votes:  383
MarketBeat's community ratings are surveys of what our community members think about Eisai and other stocks. Vote "Outperform" if you believe ESALY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ESALY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel